Dergiler / Turkish Journal of Gastroenterology
Turkish Journal of GastroenterologyFen
Dergiler yükleniyor
Katalog okunuyor.
Katalog okunuyor.
Dergiler / Turkish Journal of Gastroenterology
| Hakan AKIN, Yücel AYDIN |
| 26–30 |
| Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis | Sha-sha SHEN,Jiao-jiao GONG,Xi-wei WANG,Ling CHEN,Si QİN,Li-fan HUANG,Ya-qin CHEN,Hong REN,Qin-bing YANG,Huai-dong HU | 31–39 |
| Which drugs are risk factors for the development of gastroesophageal reflux disease? | Zeynel MUNGAN,Binnur Pınarbaşı ŞİMŞEK | 38–43 |
| Colonic acute malignant obstructions: effectiveness of self-expanding metallic stent as bridge to surgery | Pierluigi CONSOLO,Giuseppa GİACOBBE,Marcello CİNTOLO,Andrea TORTORA,Fausto FAMÀ,Maria FLORİO GİOFFRÈ,Socrate PALLİO | 40–45 |
| Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus? | Hakan AKIN,Yücel AYDIN | 41–42 |
| Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus? | Hakan AKIN, Yücel AYDIN | 41–42 |
| Which diseases are risk factors for developing gastroesophageal reflux disease? | Filiz AKYÜZ,Özlem Mutluay SOYER | 44–47 |
| Early prediction of organ failure under the revised Atlanta classification | Jian LIU,Feng CAO,Xiao-min DONG,Peng-yu Lİ,Hai-chao Lİ,Bao-ju Qİ,Fei Lİ | 46–52 |
| Medical treatment of gastroesophageal reflux disease | SERHAT BOR,İsmail Hakkı KALKAN | 48–52 |
| Influences of proton pump inhibitor on Helicobacter pylori adherence to the gastrointestinal cell lines | Marhanis Salihah OMAR,Noor Safwah DAMANHURİ,Endang KUMOLOSASİ | 53–59 |
| Treatment of reflux disease during pregnancy and lactation | Ülkü DAĞLI,İsmail Hakkı KALKAN | 53–56 |
| Percutaneous ultrasound-guided bowel biopsy of a pseudokidney mass | Maria MARSİCO,Tommaso GABBANİ,Marocchi MARGHERİTA,Sarah LUNARDİ,Maria Rosa BİAGİNİ,Vito ANNESE | 60–62 |
| Gastroesophageal reflux disease and the relationship with Helicobacter pylori | Zeynel MUNGAN,Binnur Pınarbaşı ŞİMŞEK | 61–67 |
| A rare cause of severe gastrointestinal bleeding in a thrombocytopenic patient with acute myeloid leukemia | HAYRETDİN KÖKLÜ,Evrim AKSOY KAHRAMANOĞLU,Ömer ÖZTÜRK,Yusuf BAYRAKTAR,Seyfettin KÖKLÜ | 63–64 |
| Lipoma-induced colonic intussusception in mobile cecum syndrome | Seok Youn LEE,Yong Sung KİM,Yong Sik WOO,Jaehoon JAHNG,Jung Taek OH | 65–66 |
| Accurate biopsy of bile duct without destroying duodenal papilla | Wenbo MENG,Ping YUE,Xun Lİ | 67–68 |
| When proton pump inhibitors are compared, are there specific cases in which a certain proton pump inhibitors should be particularly preferred? | Altay ÇELEBİ,Hasan YILMAZ | 68–70 |
| Narrow band imaging helps identify the ectopic opening of the common bile duct during endoscopic retrograde cholangiopancreatography | Wenbo MENG,Ping YUE,Bing BAİ,Wence ZHOU,Xun Lİ | 69–70 |
| An inflammatory myofibroblastic tumor of the small intestine in a 15-year-old girl | Xiao YU,Mao-mao ZHAO,Hao GUO,Pei-you GONG,Jun-xia Lİ,Yun-qiang WANG | 71–72 |
| What is proton pump inhibitors unresponsiveness in gastroesophageal reflux disease? How should these cases be managed? | Altay ÇELEBİ,Hasan YILMAZ | 71–72 |
| Results of 12-month rescue treatment with Teduglutide in severely active and parenteral nutrition-dependent Crohn's disease | Raffaele BORGHİNİ,Roberto CARONNA,Antonio PİCARELLİ,Enrico S. CORAZZİARİ | 73–74 |
| Results of 12-month rescue treatment with Teduglutide in severely active and parenteral nutrition-dependent Crohn's disease | Raffaele BORGHİNİ, Roberto CARONNA, Antonio PİCARELLİ, Enrico S. CORAZZİARİ | 73–74 |
| Sudden-onset sarcoidosis with severe dyspnea developing during pegylated interferon and ribavirin combination therapy for chronic hepatitis C | Soo Ki KİM,Soo Ryang KİM,Susumu IMOTO,Chi Wan KİM,Yoshitake HAYASHİ | 75–76 |
| Rifaximin in treatment of patients with Irritable bowel syndrome | Bhupinder ROMANA,Veysel TAHAN | 77–78 |
| The role of lifestyle changes in gastroesophageal reflux diseases treatment | Ülkü DAĞLI,İsmail Hakkı KALKAN | 533–537 |